When people get a special type of bone marrow transplant, giving them a common supplement called NAC twice a day might help protect their liver — in one study, far fewer patients on NAC had high levels of a liver damage marker called bilirubin compared to those who didn’t get it.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim correctly uses 'associated with' and references historical controls, indicating it is observational and not proving causation. It reports specific numerical outcomes (18% vs 68%) and a plausible biological mechanism (NAC as an antioxidant mitigating cholestasis), making it a well-phrased correlational claim. However, historical controls introduce selection bias, so the conclusion should remain cautious. The verb 'suggesting' appropriately reflects uncertainty.
More Accurate Statement
“In patients undergoing busulfan-based conditioning for hematopoietic stem cell transplantation, prophylactic administration of N-acetyl-l-cysteine at 100 mg/kg twice daily is associated with significantly lower bilirubin levels at day +20 compared to historical controls, with only 18% of NAC-treated patients versus 68% of controls exceeding 40 µmol/L, suggesting a potential association with reduced cholestatic liver injury.”
Context Details
Domain
medicine
Population
human
Subject
Patients undergoing busulfan-based conditioning for hematopoietic stem cell transplantation
Action
is associated with
Target
significantly lower bilirubin levels at day +20 and reduced cholestatic liver injury
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (0)
Contradicting (1)
The study gave NAC to patients to protect their liver during a strong chemotherapy, and it helped lower some liver enzymes — but it never checked bilirubin levels, which is what the claim is all about. So we can't say if the claim is true or false.